Global Market Analysis for Neurovascular Interventions

1. What is neurovascular interventional therapy?

Neurovascular interventional therapy is the use of minimally invasive medical devices and techniques to treat vascular diseases of the central nervous system. Neurovascular interventions help avoid surgery on high-risk areas of the body, such as the brain, spine, or neck.

This is an area with significant research and development space, as it requires highly specialized neuroscientists to perform procedures using current conventional equipment. Advances in technology and equipment are needed to minimize failure in interventional procedures.

Neurovascular interventions involve the use of minimally invasive methods, including the use of microcatheters, to treat various disorders of the brain, head, neck, and spine. Neurovascular interventional devices are used in procedures such as removing blood clots and restoring blood flow within the blood vessels of the brain during acute ischemic stroke.

There are several improvements in endovascular treatment of intracranial aneurysms with detachable coils. Recent evidence suggests that endovascular intervention is at least as effective as open surgery with fewer complications.

2. Development of the global neurovascular interventional market

The global neurovascular intervention market has witnessed advancements in the field of neurovascular therapy, which have led to the development of novel revascularization, embolization, mechanical thrombectomy, and access/support devices. The market is driven by the ability to address the unmet needs of the large number of patients with cerebrovascular diseases worldwide.

According to the World Health Organization, Italy has a high incidence of cerebrovascular diseases such as migraine and stroke. This mainly affects the 40-84 age group. This is due to the rapid changes in the way of life in European countries. The exponential growth in the number of patients with aneurysms and strokes is the factor driving the market growth. A shift in trends from traditional interventions to minimally invasive surgery for neurovascular diseases is driving companies to make new advances in the neurovascular interventions market.

However, lack of skilled neurosurgeons and high cost of neurovascular interventions and R&D are likely to restrain the market. Suppliers in this space are influenced by the strategies of large orthopaedic companies, resulting in high prices for neurovascular devices.

The global neurovascular intervention market can be segmented based on device class, disease, and region. In terms of device category, the market can be segmented into coils, carotid stents, thrombectomy devices, fluid embolization, coil-assisted balloons, coil-assisted stents, flow diverters, and microwires/catheters. The coil segment accounts for the largest share of the global neurovascular intervention market.

On the basis of disease, the global neurovascular intervention market can be classified into aneurysm, intracranial atherosclerotic disease (icad), ischemic stroke, and arteriovenous malformation (AVM). The aneurysm segment is expected to hold the largest market share in 2016. According to one study, an estimated 6 million people in the United States have unruptured brain aneurysms.

Geographically, the global neurovascular interventions market can be segmented into North America, Europe, Asia Pacific, Latin America, Africa, and the Middle East. North America is expected to dominate the global neurovascular interventions market over the forecast period owing to factors such as increasing aging population and high number of patients for various neurological disorders in the region.

The emerging economies of India, China and Japan in the Asia-Pacific region are expected to grow at a higher rate due to growth in Asia’s gross domestic product (GDP) and increased purchasing power of medical institutions.

This upcoming business intelligence report aims to be a one-stop market research solution to guide organizations in making timely and effective decisions for their business growth. Ongoing research is the culmination of our deep expertise in data science methodologies and an unparalleled understanding of the external environment and industry analysis.

Each TMR report is designed to provide a detailed review of the value chain of our current and potential customers. Help them identify the value proposition. Then help their business executives implement the right strategy to create customer value, we think. Creating and sustaining customer value is key for business executives to generate profits and increase market share for their organizations.

During our initial research, every touchpoint Zylox Tonbridge has with an organization/business allows us to understand the internal environment in which it operates and the ways in which the external environment influences its development.